Heads-Up! Don’t say I never gave ya nuttin! Hehehe!
$Rocket Pharmaceuticals (RCKT.US)$ Was gonna wait a few more days before giving this Heads-Up! But if the chart remains as bullish as the daily has been for about a month. Figure I’ll give it now and you can decide yes / no / play the price game? Hehehe. Anyways from my notes! ((((((((. FDA accepted the resubmission of the BLA for KRESLADITM (marnetegragene autotemcel; marne-cel) for the treatment of severe leukocyte adhesion deficiency-I (LAD-I).
In October 2025, KRESLADITM received a Prescription Drug User Fee Act (PDUFA) target action date for March 28, 2026.
Rocket is eligible for a Rare Pediatric Disease Priority Review Voucher (PRV), with the approval of KRESLADI. )))))))
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.Read more
Comment (1)
to post a comment
8